BioNTech (BNTX)
(Delayed Data from NSDQ)
$110.03 USD
+2.69 (2.51%)
Updated Aug 4, 2025 04:00 PM ET
After-Market: $110.59 +0.56 (0.51%) 4:34 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
BioNTech SE Sponsored ADR's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
BNTX 110.03 +2.69(2.51%)
Will BNTX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BNTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BNTX
J&J Expects Better Top-Line Growth in 2H: Can It Achieve the Goal?
MRNA Beats on Q2 Earnings & Sales, Stock Down on Lowered Sales View
BNTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zoetis Gears Up to Report Q2 Earnings: Here's What to Expect
Buy, Sell or Hold Pfizer Stock? Key Tips Ahead of Q2 Earnings
Bristol Myers Beats on Q2 Earnings and Sales, Raises '25 Sales View
Other News for BNTX
BioNTech (BNTX) Price Target Increased by Clear Street
BioNTech price target raised by $4 at Clear Street, here's why
BioNTech (BNTX) Surges on Strong Q2 Performance, Revenue Soars Over 100%
BioNTech (BNTX) Secures $1.5 Billion Upfront Payment with BMS Agreement
BioNTech (BNTX) Sees Strong Q2 Revenue Growth with Strategic Moves